Press Releases
Apceth to Manufacture First Potential One-Time Gene Therapy for Transfusion-Dependent Î’eta-Thalassemia
apceth Biopharma GmbH, a leading company for the development and manufacturing of cell and gene therapeutics, congratulates its partner bluebird bio on the acceptance and validation of its market authorization application by the European Medicines Agency (EMA). ...
Press Releases
MetP® Pharma Introduces Nascum®-Plus Against the Onset of Air Pollution-induced Inflammation
MetP® Pharma, focusing on the nasal delivery of drugs to the systemic circulation and especially to the brain, presents its Nascum®-Plus nasal gel. After application, a very thin, imperceptible protective layer forms on the nasal mucosa....
Press Releases
Orchard Therapeutics Receives EMA PRIME Designation for OTL-300, an Investigational Lentiviral Gene Therapy for the Treatment of Transfusion-Dependent Beta-Thalassemia
Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies, announced that the EMA has granted Priority Medicines (PRIME) designation to OTL-300, an investigational autologous ex vivo lentiviral...
Press Releases
Piramal Pharma Solutions launches of Xcelerate Integrated Solutions
Piramal Pharma Solutions (PPS), a global leader in Contract Development and Manufacturing Solutions, announced the launch of its Xcelerate Integrated Solutionsâ„¢ platform to address a rapidly growing market need. This platform will serve the increasing demand...
Press Releases
CPhI Madrid – ARaymondlife and DARA Pharmaceutical Packaging will exhibit the NFL line
RayDyLyo® a breakthrough innovation with multiples benefits RayDyLyo® is an all-plastic capping solution designed to work with all ISO stopper configurations (serum and lyo). Customers select and validate the stoppers which are assembled automatically by ARaymondlife....
Press Releases
OTTR First to Provide Management Software for Immune Effector Cell (IEC) Cancer Treatment
OTTR, the leading provider of solid organ transplant and cellular therapy patient tracking software, is introducing a new module for immune effector cells (IEC) within its CompleteCellular solution. IEC is a promising category of cancer treatment...
Press Releases
Aptar Pharma launches PureHale, a new portable and ready-to-use upper respiratory drug delivery solution
Aptar Pharma, a leading drug delivery systems provider, continues its commitment to meeting new market trends with the release of an industry first, PureHale, a new portable and ready-to-use drug delivery solution designed for upper respiratory care. ...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read